hero image

Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources

January 30, 2012 News Release

-- Addition of Seasoned HR Leader Supports Commitment to Driving Culture of Excellence --


WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ:BIIB) today announced that Kenneth DiPietro has been named Executive Vice President, Human Resources. Mr. DiPietro will lead the development and execution of the company’s global human resources strategy, including talent management, talent acquisition, compensation and benefits, and global human resources operations and systems. He will report to Chief Executive Officer George A. Scangos, Ph.D.

Mr. DiPietro has more than 30 years of experience in both human resources and organizational development, including broad cultural transformation and corporate re-engineering across Global 500 companies. He joins Biogen Idec from Lenovo Group, where he served as Senior Vice President, Human Resources. He previously was Corporate Vice President, Human Resources at Microsoft Corporation and Vice President, Human Resources at Dell Computer Corporation.

“I am thrilled to welcome Kenneth DiPietro to Biogen Idec,” said Dr. Scangos. “Culture is what separates a good company from a great company, and in Ken, we have a proven leader who I’m confident will foster and build upon our culture of excellence as we enter a period of great opportunity for Biogen Idec.”

Mr. DiPietro added, “I couldn’t be more excited to join Biogen Idec. This is an exciting moment in time for the company, and I share George and the leadership team’s belief in driving cultural excellence as a way of attracting and retaining talent, and as key to realizing business success. I look forward to being at the forefront of driving that effort.”

At Lenovo, Mr. DiPietro, was responsible for coordinating the acquisition integration of IBM’s PC Business, the successful recruitment of more than 120 senior global leaders, and reengineering the HR function to elevate operating efficiency and capacity. From 2003 to 2005, he served as Corporate Vice President, Human Resources at Microsoft Corporation. From 1999 to 2002, Mr. DiPietro worked as Vice President, Human Resources at Dell Computer Corporation. Prior to that, he spent 17 years at PepsiCo, serving in a range of human resource and general management positions. Mr. DiPietro received his B.S. in Labor Relations from Cornell University.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates nearly $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.



Biogen Idec
Amanda Brown Galgay, 781-464-3260
Kia Khaleghpour, 781-464-2442



May 16, 2024
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the Phase 1/2 ALSpire study Biogen and Ionis continue their long-standing commitment to developing therapies for ALS given the devastating impact of

May 14, 2024
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the